Editorial: Special issue on rare cancers

Affiliations

¹ MyPART, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address: abby.sandler@nih.gov.
² Rare Tumor Initiative, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
³ Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Editorial

Abby Sandler et al. Curr Probl Cancer. 2021 Aug.

. 2021 Aug;45(4):100774.

doi: 10.1016/j.currproblcancer.2021.100774. Epub 2021 Jul 8.

¹ MyPART, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address: abby.sandler@nih.gov.
² Rare Tumor Initiative, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
³ Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

No abstract available

References

1. US NIH National Cancer Institute: Dictionary of Cancer Terms: “rare cancer”. 2021. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-c....accessedJune 23, 2021
1. Keat N, Law K, McConnell A, Seymour M, Welch J, Trimble T, et al. International Rare Cancers Initiative (IRCI). Ecancermedicalscience. 2013;7:ed20. doi: 10.3332/ecancer.2013.ed20 - DOI - PMC - PubMed
1. Greenlee RT, Goodman MT, Lynch CF, Platz CE, Havener LA, Howe HL. The occurrence of rare cancers in U.S. adults, 1995–2004. Public Health Rep. 2010;125:28–43. doi: 10.1177/003335491012500106 - DOI - PMC - PubMed
1. DeSantis CE, Kramer JL, Jemal A. The burden of rare cancers in the United States. CA Cancer J Clin. 2017;67:261–72. doi: 10.3322/caac.21400 - DOI - PubMed
1. Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18:1022–39. doi: 10.1016/S1470-2045(17)30445-X - DOI - PubMed